trending Market Intelligence /marketintelligence/en/news-insights/trending/CwUfiehpOBsIkhbPElIMkg2 content esgSubNav
In This List

Guided Therapeutics' Chinese partner to limit ownership in company

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Guided Therapeutics' Chinese partner to limit ownership in company

China's Shandong Yaohua Medical Instrument Corp. agreed to limit its ownership in Guided Therapeutics Inc. to 4.99%. The companies amended an agreement under which Guided Therapeutics was to issue $1 million of its shares to the Chinese firm.

Guided Therapeutics will now withhold stocks that it would have otherwise issued and issue them later to maintain Shandong Yaohua's ownership at or below 4.99%.

Guided Therapeutics will issue three warrants as consideration for the limitation. Each warrant will be exercisable for 15,000 common shares at $1.25 apiece and will be issued with the next three licensing payments made by Shandong.

The licensing agreement relates to the rights to Guided Therapeutics' LuViva cervical scan in China.